Uaprasert Noppacharn, Chanswangphuwana Chantiya, Akkawat Benjaporn, Rojnuckarin Ponlapat
Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.
Blood Coagul Fibrinolysis. 2013 Apr;24(3):261-8. doi: 10.1097/MBC.0b013e32835baccb.
Heparin-induced thrombocytopenia (HIT) is a serious immunological complication of heparin administration. Diagnosis of HIT is challenging, especially in critically ill patients. The clinical scoring model for predicting HIT is helpful for guiding clinical decision. We analysed data of patients who underwent the heparin-induced platelet aggregation (HPA) test from 2006 to 2010 and compared diagnostic performance of the novel model HIT expert probability ('HEP'), which has been validated in a population mainly comprising surgical patients first, by the previously published model '4Ts' score. Clinical courses of the patients were also reviewed to ensure that HPA test results were accurate. There were 47 suspected HIT patients. The majority was from medical (70.2%) and/or critical care (61.7%) units. Ten (21.3%) yielded positive HPA. Among positive HPA patients, eight were medical patients. The HEP score ranged from -3 to 13, whereas the 4Ts score ranged from 3 to 7 in positive HPA patients. Both HEP and 4Ts scores were significantly higher in positive HPA than in negative HPA patients (5.35 vs. 1.81, P=0.010 and 4.85 vs. 3.32, P=0.001, respectively). The HEP score did not display better diagnostic performance than the 4Ts score, with receiver operating characteristic (ROC) area under curve of 0.72 and 0.79 (P=0.31), respectively. The HEP score did not show better diagnostic performance than the 4Ts score for predicting HIT in our population. A large prospective validation in different sets of patients is warranted.
肝素诱导的血小板减少症(HIT)是肝素给药的一种严重免疫并发症。HIT的诊断具有挑战性,尤其是在危重症患者中。预测HIT的临床评分模型有助于指导临床决策。我们分析了2006年至2010年接受肝素诱导的血小板聚集(HPA)试验的患者数据,并首先通过先前发表的“4Ts”评分模型,比较了新型模型HIT专家概率(“HEP”)在主要由外科患者组成的人群中的诊断性能。还回顾了患者的临床病程,以确保HPA试验结果准确。有47例疑似HIT患者。大多数来自内科(70.2%)和/或重症监护(61.7%)病房。10例(21.3%)HPA结果为阳性。在HPA阳性患者中,8例为内科患者。阳性HPA患者的HEP评分范围为-3至13,而4Ts评分范围为3至7。HEP和4Ts评分在HPA阳性患者中均显著高于HPA阴性患者(分别为5.35对1.81,P = 0.010和4.85对3.32,P = 0.001)。HEP评分的诊断性能并不优于4Ts评分,受试者工作特征(ROC)曲线下面积分别为0.72和0.79(P = 0.31)。在我们的人群中,HEP评分在预测HIT方面的诊断性能并不优于4Ts评分。有必要在不同患者组中进行大规模的前瞻性验证。